Search - tctmd.com

Displaying 121 - 140 of 183

Sort: Relevancy | Date

Presentation

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Presenter: Muthia Vaduganathan

March 22, 2016

Presentation

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

Presenter: Paul Myles

February 24, 2016

Presentation

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Presenter: Matteo Bianco

January 20, 2016

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Presentation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Presenter: Ying Xian

May 27, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Presentation ACC 2015

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Presenter: Marc S. Sabatine

March 14, 2015

Presentation

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Presenter: Martine Gilard

March 10, 2015

Presentation CADECI 2015

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Presenter: DR. JOSE LUIS LEIVA PONS

February 20, 2015

Presentation

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Stable CAD

Presenter: M. Hanon

September 30, 2014

Presentation TCT 2014

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Harvey D. White

September 15, 2014

Presentation TCT 2014

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Freek W.A. Verheugt

September 14, 2014

Presentation TCT 2014

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Anthony A. Bavry

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

Presentation

Aspirin Treatment and Outcomes After PCI

Presenter: Katharina Mayer

August 25, 2014

Presentation

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Presenter: H.M. Hall

August 13, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Advertisement

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Stable CAD

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Aspirin Treatment and Outcomes After PCI

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content